Nat. Rev. Endocrinol. doi: /nrendo

Slides:

Advertisements

Similar presentations

Nat Clin Pract Endocrinol Metab 3: 279–289 doi: /ncpendmet0447

Advertisements

Nat. Rev. Endocrinol. doi: /nrendo

Plasma insulin concentrations (A) and insulin secretion rates (B) in response to molar increments of plasma glucose concentration during the graded glucose.

Figure 2 Electromechanical properties of OIHPs

Figure 6 Selected examples of TERS applications in material systems

Figure 3 Childhood craniopharyngioma

Figure 1 Framework for variant interpretation of phaeochromocytomas and/or paragangliomas (PPGLs) susceptibility genes into five classes based on the likelihood.

Figure 2 Regions of Africa exposed to undernutrition

Figure 2 Pathophysiology of hyperglycaemia in T2DM

Figure 1 Anatomy of the spinal column

with undiagnosed diabetes mellitus by three diagnostic criteria

Figure 4 Amino acid structure of short-acting and long-acting insulins

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Mendelian randomization study

Figure 5 BMI and cardiorespiratory fitness levels

Nat. Rev. Endocrinol. doi: /nrendo

Figure 4 BMI and mortality in patients with heart failure

Figure 5 MRI of childhood craniopharyngioma

Figure 2 Bad-metal behaviour and electron correlations

Figure 1 The Beckwith–Wiedemann spectrum

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 5 Risk factor control in the intensive treatment group

Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 3 Polysaccharides from plants and mushrooms

Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Endocrinol. doi: /nrendo

chemotherapy for patients with MC versus those with AC

Figure 2 Endocrine dysfunction in mitochondrial disease and their associated gene defects Figure 2 | Endocrine dysfunction in mitochondrial disease and.

Figure 1 Cardiovascular risk and disease across the life-course

Figure 3 Clinical algorithms in the management of NASH and diabetes mellitus Figure 3 | Clinical algorithms in the management of NASH and diabetes mellitus.

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Nat. Rev. Endocrinol. doi: /nrendo

Figure 2 Clinical vignette and putative causal relationships

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Figure 6 Combining population-wide and high-risk strategies

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Endocrinol. doi: /nrendo

Glycated hemoglobin (HbA1c) trajectories among children during the first 5 years after diagnosis of type 1 diabetes, stratified by diagnostic era and diagnostic.

Figure 2 Gut microbial gene content and development of T1DM

Figure 5 Schematic overview of a clinical decision-support

(A) Correlation between change in HbA1c and change in weight from baseline to week 24 in the liraglutide group. (A) Correlation between change in HbA1c.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Endocrinol. doi: /nrendo

Figure 1 Timeline of pancreatic islet transplantation

Figure 1 Exercise enhances insulin sensitivity

Nat. Rev. Endocrinol. doi: /nrendo

Association between antibiotic purchases and glycated hemoglobin (HbA1c) values in patients with and without diabetic nephropathy. Association between.

Diabetes and Pregnancy

Figure 3 Determination of the primary site

Figure 3 Global iodine status and mandatory salt iodization

Continuous associations

This pooled data from 11 prospective cohort studies with 650,386 white adults found a significant correlation in all-cause mortality when waist circumference.

A1C (A) and serum glycated albumin (GA) (B) levels in 47 pregnant women (study 1) divided according to gestational period into group I (21–24 weeks; n.

Figure 5 Algorithm for the management of hypertension

Figure 2 Diffusio-osmotic process for osmotic energy conversion

Nat. Rev. Endocrinol. doi: /nrendo

Nat. Rev. Mater. doi: /natrevmats

Presentation transcript:

Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.127 Figure 3 Diagnostic sensitivity of HbA1c and glycated albumin according to BMI Figure 3 | Diagnostic sensitivity of HbA1c and glycated albumin according to BMI. a | Nonobese cohort. The diagnostic sensitivity was 37% (25–50%) for HbA1c, 42% (30–55%) for glycated albumin (GA) and 72% (59–82%) for the combination of HbA1c and GA (HbA1c + GA). The corresponding specificities were 76% (67–83%), 78% (69–85%) and 61% (52–70%), respectively. b | Obese cohort. The diagnostic sensitivity was 64% (43–81%) for HbA1c, 16% (6–38%) for GA and 72% (50–87%) for HbA1c + GA. The corresponding specificities were 74% (57–86%), 87% (71–95%) and 66% (49–80%), respectively. c | Entire cohort. The diagnostic sensitivity was 45% (34–56%) for HbA1c, 34% (25–45%) for GA and 72% (61–81%) for HbA1c + GA. The corresponding specificities were 76% (68–82%), 80% (73–86%) and 62% (54–70%),respectively. The data are presented as the mean ± 95% CI. The dashed lines show the presence or absence of overlap with the 95% CI when HbA1c and GA are combined. *P < 0.001. Adapted with permission of the American Association for Clinical Chemistry. Sumner, A. E. et al. Glycated albumin identifies prediabetes not detected by haemoglobin A1c: The Africans in America Study. Clin. Chem. 62, 1524–1532 (2016)106. Adapted with permission of the American Association for Clinical Chemistry. Sumner, A. E. et al. Glycated albumin identifies prediabetes not detected by haemoglobin A1c: The Africans in America Study. Clin. Chem. 62, 1524–1532 (2016). Utumatwishima, J. N. et al. (2017) Reversing the tide — diagnosis and prevention of T2DM in populations of African descent Nat. Rev. Endocrinol. doi:10.1038/nrendo.2017.127